SMARCA4 and colitis: Furthermore, we found that the downregulation of miR-222-3p relieved oxidative stress in IECs via targeting BRG1 to promote the Nrf2/HO-1 signaling pathway, thereby improving colitis and tumorigenesis (Figure 1).